Publication Name	World Journal of Methodology
Manuscript ID	119385
Country	Saudi Arabia

Category	Urology & Nephrology
Manuscript Type	Meta-Analysis
Article Title	Glucagon-like receptor-1 agonists and impotence: A meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Hyder Osman Mirghani and Asawir Mohammed AlQurashi
Funding Agency and Grant Number
Corresponding Author	Hyder Osman Mirghani, Full Professor, MD, Internal Medicine, Faculty of Medicine, University of Tabuk, Prince Fahd Bin Sulta, Tabuk 51941, Saudi Arabia. s.hyder63@hotmail.com
Key Words	Glucagon-like peptide receptors-1 agonists; Erectile dysfunction impotence; Autonomic nervous system
Core Tip	Glucagon-like peptide receptors-1 agonists (GLP-1 agonists) have revolutionized the treatment of obesity and diabetes due to their potent effects on weight and glycemic control, and cardiorenal protection. However, emerging reports and post-marketing surveillance have raised concerns regarding erectile dysfunction (ED) or impotence in a subset of male patients. Impotence is common and is associated with diabetes, obesity, and cardiovascular risk factors. Drugs that mitigate both impotence and cardiovascular risk are attractive. This review gave an insight about the effects of GLP-1 agonists and ED.
Citation	Mirghani HO, AlQurashi AM. Glucagon-like receptor-1 agonists and impotence: A meta-analysis. World J Methodol 2026; In press

Received	2026-01-26 00:42
Peer-Review Started	2026-01-26 00:42
First Decision by Editorial Office Director	2026-01-30 09:04
Return for Revision	2026-01-30 09:04
Revised	2026-02-02 03:36
Publication Fee Transferred
Second Decision by Editor	2026-02-25 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-02-25 08:42
Articles in Press	2026-02-25 08:42
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com